Loma Linda University

Enrollment Information
Call us at: 909-558-1000

Faculty Directory
  
Christopher Morris, MD
Professor, Pediatrics
School of Medicine
Research & Grantsmanship    Funded Research Project (PI)
  • Prophylaxis Against Regimen Related Toxicity Following Bone Marrow Transplantation With Continuous Infusion Antithrombin-III ( 1/1996 - 1/1997 )
  • Red Cell Adhesion of Sickle and Polycythemia Vera Blood ( 1/1987 - 1/1992 )
  • CYCLOPHOSPHAMIDE ETOPOSIDE AND FRACTIONATED TOTAL BODY IRRADIATION FOLLOWED BY ALLOGENEIC STEM CELL TRANSPLANTATION FOR PATIENTS WITH LEUKEMIA, MYELODYSPLASIA, OR LYMPHOMA ( 4/2003 - Present )
  • BUSULFAN, CYCLOPHOSPHAMIDE, AND ETOPOSIDE AS CONDITIONING THERAPY FOR STEM CELL TRANSPLANTATION FOR PATIENTS WITH LEUKEMIA ( 10/2002 - Present )
  • UARK 2000-44, A RANDOMIZED TRIAL OF ANTI-CD25 MoAb IN REDUCING THE INCIDENCE OF SEVERE GRAFT-VERSUS-HOST-DISEASE (GVHD) IN PATIENTS WITH HIGH-RISK HEMATOLOGICAL MALIGNANCIES RECEIVING DELAYED GVHD PROPHYLAXIS ( 1/2000 - Present )
  Funded Research Project (CI)
  • Endothelial cell adhesion molecule expression in response to thrombin stimulation or anti-thrombin III deficiency ( 1/1998 - 1/1999 )
  Abstracts Reporting Research -- Non-Peer Reviewed
  • FACT Program Director - After several years performing pediatric blood and and marrow transplants, the program reached the required number of transplants within the required time frame and established a documented standardized methodology for blood and marrow transplant. Accreditation of the program was granted by the Foundation for Hematopoietic Cell Therapy (FACT) in May 2007. ( 5/2007 - Present )
  • Program Director Blood and Marrow Transplant - I was recruited to Loma Linda in 2002 to develop and administer a program for blood and marrow transplant. This included development of a new pediatric transplant program and administration of a small adult transplant program. ( 5/2002 - Present )